Nirmatrelvir
Cat. No.：YN252141
CAS No. ：2628280-40-8
| 产品名称: | Nirmatrelvir |
| CAS No.: | 2628280-40-8 |
| Chemical Name: | (1R,2S,5S)-N-[(1S)-1-cyano-2-[(3S)-2-oxo-3-pyrrolidinyl]ethyl]-3-[(2S)-3,3-dimethyl-1-oxo-2-[(2,2,2-trifluoroacetyl)amino]butyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide |
| Synonyms: | PF-07321332 |
| 分子量: | 499.5 |
| 分子式: | C23H32F3N5O4 |
| SMILES: | FC(F)(F)C(N[C@@H](C(C)(C)C)C(N1C[C@@](C2(C)C)([H])[C@@]2([H])[C@H]1C(N[C@H](C#N)C[C@H]3C(NCC3)=O)=O)=O)=O |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Nirmatrelvir (PF-07321332) 是一种有效的口服活性SARS-CoV?3CLPRO?抑制剂。Nirmatrelvir (PF-07321332) 对 SARS-CoV-2 病毒有针对性，可用于 COVID-19 研究。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Owen, D.R., Allerton, C.M.N., Anderson, A.S., et al.An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19Science374(6575),1586-1593(2021)
